Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
- PMID: 21507239
- PMCID: PMC3094199
- DOI: 10.1186/1471-2180-11-80
Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
Abstract
Background: Bacille Calmette-Guerin (BCG) is currently the only available vaccine against tuberculosis (TB) and comprises a heterogeneous family of sub-strains with genotypic and phenotypic differences. The World Health Organization (WHO) affirms that the characterization of BCG sub-strains, both on genomic and proteomic levels, is crucial for a better comprehension of the vaccine. In addition, these studies can contribute in the development of a more efficient vaccine against TB. Here, we combine two-dimensional electrophoresis (2DE) and mass spectrometry to analyse the proteomic profile of culture filtrate proteins (CFPs) from M. bovis BCG Moreau, the Brazilian vaccine strain, comparing it to that of BCG Pasteur. CFPs are considered of great importance given their dominant immunogenicity and role in pathogenesis, being available for interaction with host cells since early infection.
Results: The 2DE proteomic map of M. bovis BCG Moreau CFPs in the pH range 3-8 allowed the identification of 158 spots corresponding to 101 different proteins, identified by MS/MS. Comparison to BCG Pasteur highlights the great similarity between these BCG strains. However, quantitative analysis shows a higher expression of immunogenic proteins such as Rv1860 (BCG1896, Apa), Rv1926c (BCG1965c, Mpb63) and Rv1886c (BCG1923c, Ag85B) in BCG Moreau when compared to BCG Pasteur, while some heat shock proteins, such as Rv0440 (BCG0479, GroEL2) and Rv0350 (BCG0389, DnaK), show the opposite pattern.
Conclusions: Here we report the detailed 2DE profile of CFPs from M. bovis BCG Moreau and its comparison to BCG Pasteur, identifying differences that may provide relevant information on vaccine efficacy. These findings contribute to the detailed characterization of the Brazilian vaccine strain against TB, revealing aspects that may lead to a better understanding of the factors leading to BCG's variable protective efficacy against TB.
Figures





Similar articles
-
Exploring the Potential Role of Moonlighting Function of the Surface-Associated Proteins From Mycobacterium bovis BCG Moreau and Pasteur by Comparative Proteomic.Front Immunol. 2019 Apr 26;10:716. doi: 10.3389/fimmu.2019.00716. eCollection 2019. Front Immunol. 2019. PMID: 31080447 Free PMC article.
-
Differences in responses to the intracellular macrophage environment between Mycobacterium bovis BCG vaccine strains Moreau and Pasteur.Mem Inst Oswaldo Cruz. 2023 Oct 13;118:e230070. doi: 10.1590/0074-02760230070. eCollection 2023. Mem Inst Oswaldo Cruz. 2023. PMID: 37851722 Free PMC article.
-
Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains.Hum Vaccin Immunother. 2022 Dec 31;18(1):1989913. doi: 10.1080/21645515.2021.1989913. Epub 2021 Nov 12. Hum Vaccin Immunother. 2022. PMID: 34766868 Free PMC article.
-
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28. Vaccine. 2015. PMID: 26319069 Free PMC article. Review.
-
Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.Tuber Lung Dis. 1999;79(4):243-50. doi: 10.1054/tuld.1999.0206. Tuber Lung Dis. 1999. PMID: 10692993 Review.
Cited by
-
Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.Mol Cell Proteomics. 2013 Aug;12(8):2081-95. doi: 10.1074/mcp.M113.027318. Epub 2013 Apr 24. Mol Cell Proteomics. 2013. PMID: 23616670 Free PMC article.
-
Proteomic contributions to our understanding of vaccine and immune responses.Proteomics Clin Appl. 2015 Dec;9(11-12):972-89. doi: 10.1002/prca.201500054. Epub 2015 Sep 10. Proteomics Clin Appl. 2015. PMID: 26172619 Free PMC article. Review.
-
Commonly administered bacille Calmette-Guerin strains induce comparable immune response.Int J Clin Exp Med. 2015 Sep 15;8(9):15834-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26629084 Free PMC article.
-
Arming the troops: Post-translational modification of extracellular bacterial proteins.Sci Prog. 2020 Oct-Dec;103(4):36850420964317. doi: 10.1177/0036850420964317. Sci Prog. 2020. PMID: 33148128 Free PMC article. Review.
-
Comparative Proteomic Profiling of Mycobacterium tuberculosis and the Thai Vaccine Strain Mycobacterium bovis Bacille Calmette-Guerin Tokyo172: Diverse Biomarker Candidates for Species Differentiation.J Glob Infect Dis. 2018 Oct-Dec;10(4):196-200. doi: 10.4103/jgid.jgid_149_17. J Glob Infect Dis. 2018. PMID: 30581260 Free PMC article.
References
-
- WHO. Global Tuberculosis Control, Surveillance, Planning, Financing. Geneva: World Health Organization; 2008.
-
- Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, Raviglione M. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet. 2006;368:2142–2154. doi: 10.1016/S0140-6736(06)69863-2. - DOI - PubMed
-
- Calmette A, Guerin C, Negre L, Bocquet A. Sur la vaccination preventive des enfants nouveau-nés contre la tuberculose par le BCG. Ann Inst Pasteur (Paris) 1927;3:201–208.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources